Drug-resistant and multidrug-resistant tubercle bacilli

International Journal of Antimicrobial Agents

Volumn 13, Issue 2, 1999, Pages 93-97

  Petrini, Björn ^a   Hoffner, Sven ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Drug resistance; M. tuberculosis; MDR TB; Multidrug resistance; Tuberculosis

Indexed keywords

ISONIAZID; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

CHEMOTHERAPY; CULTURAL ANTHROPOLOGY; CZECH REPUBLIC; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; UNITED KINGDOM; ZIMBABWE;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0033213497     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00111-9     Document Type: Review

References (20)

1. American Thoracic Society. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the elimination of tuberculosis, MMWR Morb Mortal Wkly Rep 1993;42:1-8.
2. Cynamon M.H. TB resistance mechanisms and future prospects for treatment. Clin. Microbiol. Newslett. 16:1994;20-21.
3. Inderlied C.B., Salfinger M. Antimicrobial agents and susceptibility tests: Mycobacteria. Murray P.R. Manual of Clinical Microbiology. 1995;1385-1404 ASM Press, Washington, DC.
4. Vestal AL. Procedures for isolation and identification of mycobacteria. US Public Health Serv Publ 75-8230. Atlanta, GA: CDC, 1975.
5. Roberts G.D., Goodman N.L., Heifets L. et al. Evaluation of Bactec radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18:1983;689-696.
6. Cole S., Telenti A. Drug resistance in Mycobacterium tuberculosis. Eur. Respir. J. 8(Suppl. 20):1995;701-713.
7. Hoffner S.E., Källenius G. Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur. J. Clin. Infect. Dis. 7:1988;188-190.
8. Mikusova K., Slayden R.A., Besra G.S., Brennan P.J. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob. Agents Chemother. 39:1995;2484-2489.
9. Telenti A., Philipp W.J., Sreevatsan S. et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3:1997;567-570.
10. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am. Rev. Respir. Dis. 147:1993;1311-1320.
11. Passannante M., Gallagher C.T., Reichman L.B. Preventive therapy for contacts of multidrug-resistant tuberculosis. Chest. 106:1994;431-434.
12. Lutfey M., Della-Latta P., Kapur V. et al. Independent origin of mono-rifampicin-resistant Mycobacterium tuberculosis in patients with AIDS. Am. J. Respir. Crit. Care Med. 153:1996;837-840.
13. Bifani P.J., Plicarytis B.B., Kapur V. et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. J. Am. Med. Assoc. 275:1996;452-457.
14. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons in Florida and New York 1988-1991, MMWR Morb Mortal Wkly Rep 1991;40:585-591.
15. CDC. National action plan to combat multidrug-resistant tuberculosis, MMWR Morb Mortal Wkly Rep 1992;41:5-47.
16. Cohn D., Bustreo F., Raviglione M.C. Drug resistance in tuberculosis: review of the worldwide situation and WHO/IUATLD global surveillance project. Clin. Infect. Dis. 24(Suppl. 1):1997;121-130.
17. Vareldzis B.P., Grosset J., de Kantor I. et al. Drug-resistant tuberculosis: laboratory issues. Tuber. Lung Dis. 75:1994;1-7.
18. Laszlo A., Rahman M., Raviglione M., Bustreo F. WHO/IUATLD Network of Supranational Reference Laboratories: Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int. J. Tuber. Lung Dis. 1:1997;231-238.
19. WHO. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Geneva: WHO/TB/97,229.
20. The Swedish Tuberculosis Index 1997. Solna: Swedish Institute for Infectious Disease Control, 1999.